• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Milestone Scientific logs Q2 beat

August 15, 2017 By Sarah Faulkner

Milestone ScientificInjection device maker Milestone Scientific (NYSE:MLSS) topped expectations on Wall Street today with its second quarter results.

The Livingston, N.J.-based company posted a net loss of -$1.5 million on sales of $2.5 million for the 3 months ended June 30, for bottom-line growth of 6.8% on sales growth of 4.2% compared with the same period last year.

Adjusted to exclude 1-time items, earnings per share were -5¢, in line with consensus on The Street, where analysts were looking for sales of $2.4 million.

“I am pleased to report that the wand dental business continues to grow profitably and we are making steady progress towards commercializing our first medical instrument following successful FDA marketing clearance of the CompuFlo Epidural Instrument earlier this year. We recently announced treatment of our first patient in the U.S. with the CompuFlo Epidural Instrument at the University of Miami Hospital. Outside the U.S., we are actively recruiting distribution partners for the CompuFlo Epidural Instrument in all the important international markets,” CEO Daniel Goldberger said in prepared remarks.

“Our wand dental business continues to strengthen, highlighted by a 70% increase in domestic handpiece sales, as we launched several promotional programs through the exclusive product sales team at Henry Schein, our distributor for the U.S. and Canada. We believe these marketing initiatives along with further investments in education and research activities with our worldwide team of key opinion leaders should build market awareness and serve to accelerate revenue growth in the second half of 2017 and throughout 2018,” Goldberger added.

See the best minds in medtech live at DeviceTalks Boston on Oct. 2. 

Filed Under: Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Pain Management, Pharmaceuticals, Wall Street Beat Tagged With: milestonescientific

IN CASE YOU MISSED IT

  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS